HepaHope News

01.21.11
HepaHope submitted an application to the USDA, APHIS in support of a dealer's license to market the veterinary application of the HepaPheresis™ System.

12.29.10
HepaHope will conduct veterinary hospital field tests on animals experiencing acute liver failure, using the HepaPheresis™ System based on USDA's, APHIS (Animal Plant Health Inspection Service) approval letter to perform these studies.

10.29.10
HepaHope is looking to establish a Veterinary application of it's Bioartificial liver program to treat acute liver failures in companion animals.

07.21.10
In an FDA teleconference, the FDA stated that no more in vivo efficacy studies in animals are needed to remove the clinical hold, only a well designed in vitro pharmacodynamic study that shows BioReactor function (ammonia clearance, for example) in the HepaPheresis™ System is needed.

01.12.09
HepaHope signs agreement with HepaHope Korea to manufacture and distribute the Chemosensitivity Testing System and BioTester™

11.04.08
HepaHope presents research data at San Francisco AASLD conference

08.22.08
HepaHope signs an agreement with Quintiles for its clinical trial program

• News
• Press Releases
• Publications
• + Product
• + Corporate & Financial

Terms of Use | Privacy Policy | Site Map